Peptilogics

Precision-engineered peptides to cure medical device infections

Pittsburgh, United States · Founded 2013 · $113.4M raised

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$113.4M
Last Round
$78.0M Series BOct 2025
Rounds
3

About

Peptilogics is a clinical-stage biotechnology company that uses a human-AI peptide engineering platform to design novel peptide therapeutics. Its lead program, PLG0206, is in a pivotal Phase 2/3 trial for prosthetic joint infections (PJI) — the first potential approved therapy for the condition — and holds FDA Orphan Disease Designation, Fast Track, and QIDP status.

Summary

Peptilogics is a Biotech company based in Pittsburgh, United States, founded in 2013. It has raised $113.4M in total across 3 rounds, most recently a $78.0M Series B round in Oct 2025.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2025
$78.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Peptilogics on Indexed.vc
<a href="https://indexed.vc/companies/peptilogics"><img src="https://indexed.vc/api/badge/company/peptilogics" alt="Peptilogics on Indexed.vc" width="260" height="76" /></a>